Idera Pharmaceuticals Employee Directory
Biotechnology ResearchNorth Carolina, United States11-50 Employees
Based in Durham, North Carolina, Idera Pharmaceuticals operates in the biotechnology research sector. In September 2022, Idera completed the acquisition of Aceragen, a privately held company focused on rare disease therapies, expanding into rare, orphan pulmonary and rheumatic diseases. The subsequent wind-down of Aceragen began in mid-2023, shaping the current corporate trajectory of the combined entity. The company’s historical emphasis has been on addressing diseases with limited or no available treatments, a characteristic of its rare-disease focus. As a small organization within biotechnology research, it centers its activities in a niche area of need. The information provided does not detail active product programs beyond Aceragen’s wind-down.
1-888-653-2347 
support@leadiq.com 
